Concepedia
Statistics
Publications
3
Citations
71
H-Index
Active since
2022
Affiliations
Swiss Group For Clinical Cancer Research(Current)
University Hospital of Bern
University Hospital of Geneva
University Hospital of Basel
University of Bern
Lisa Holer is an author at Swiss Group For Clinical Cancer Research.
Publications per year
2022–2024
A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer
Christoph Mamot, Andreas Wicki, Ursula Hasler-Strub et al. · Scientific Reports · 2023 · 38 citations · Full text
Fibroblast growth factor receptor (FGFR) inhibitor rogaratinib in patients with advanced pretreated squamous-cell non-small cell lung cancer over-expressing FGFR mRNA: The SAKK 19/18 phase II study
Alfredo Addeo, Sacha I. Rothschild, Lisa Holer et al. · Lung Cancer · 2022 · 17 citations · Full text
TLD-1, a novel liposomal doxorubicin, in patients with advanced solid tumors: Dose escalation and expansion part of a multicenter open-label phase I trial (SAKK 65/16)
Ilaria Colombo, Kira‐Lee Koster, Lisa Holer et al. · European Journal of Cancer · 2024 · 16 citations · Full text
1–3 of 3